These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29572862)

  • 21. Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.
    Fischer K; Camara A; Troupin C; Fehling SK; Strecker T; Groschup MH; Tordo N; Diederich S
    Transbound Emerg Dis; 2020 Mar; 67(2):724-732. PubMed ID: 31627257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae.
    LaVergne SM; Sakabe S; Kanneh L; Momoh M; Al-Hassan F; Yilah M; Goba A; Sandi JD; Gbakie M; Cubitt B; Boisen M; Mayeux JM; Smira A; Shore K; Bica I; Pollard KM; Carlos de la Torre J; Branco LM; Garry RF; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
    J Infect Dis; 2020 Oct; 222(9):1488-1497. PubMed ID: 32436943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.
    Geisen C; Kann G; Strecker T; Wolf T; Schüttfort G; van Kraaij M; MacLennan S; Rummler S; Weinigel C; Eickmann M; Fehling SK; Krähling V; Seidl C; Seifried E; Schmidt M; Schäfer R
    Vox Sang; 2016 May; 110(4):329-35. PubMed ID: 26766162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological Investigation of Laboratory-Confirmed and Suspected Ebola Virus Disease Patients During the Late Phase of the Ebola Outbreak in Sierra Leone.
    Liu Y; Sun Y; Wu W; Li A; Yang X; Zhang S; Li C; Su Q; Cai S; Sun D; Hu H; Zhang Z; Yang X; Kamara I; Koroma S; Bangura G; Tia A; Kamara A; Lebby M; Kargbo B; Li J; Wang S; Dong X; Shu Y; Xu W; Gao GF; Wu G; Li D; Liu WJ; Liang M
    Virol Sin; 2018 Aug; 33(4):323-334. PubMed ID: 30066045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
    Anderson MS; Niemuth NA; Sabourin CL; Badorrek CS; Bounds CE; Rudge TL
    PLoS One; 2020; 15(8):e0238196. PubMed ID: 32841291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017.
    Fischer K; Suluku R; Fehling SK; Jabaty J; Koroma B; Strecker T; Groschup MH; Diederich S
    Emerg Infect Dis; 2020 Apr; 26(4):760-763. PubMed ID: 32186496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Diagnostic Performance of Three Indirect Enzyme-Linked Immunosorbent Assays for the Detection of IgG Antibodies to Ebola Virus in Human Sera.
    Paweska JT; Moolla N; Storm N; Msimang V; Conteh O; Weyer J; Vuren PJV
    Viruses; 2019 Jul; 11(8):. PubMed ID: 31344850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Prototype Filovirus Recombinant Antigen Immunoassays.
    Boisen ML; Oottamasathien D; Jones AB; Millett MM; Nelson DS; Bornholdt ZA; Fusco ML; Abelson DM; Oda S; Hartnett JN; Rowland MM; Heinrich ML; Akdag M; Goba A; Momoh M; Fullah M; Baimba F; Gbakie M; Safa S; Fonnie R; Kanneh L; Cross RW; Geisbert JB; Geisbert TW; Kulakosky PC; Grant DS; Shaffer JG; Schieffelin JS; Wilson RB; Saphire EO; Branco LM; Garry RF; Khan SH; Pitts KR;
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S359-67. PubMed ID: 26232440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological Evidence for the Circulation of Ebolaviruses in Pigs From Sierra Leone.
    Fischer K; Jabaty J; Suluku R; Strecker T; Groseth A; Fehling SK; Balkema-Buschmann A; Koroma B; Schmidt KM; Atherstone C; Weingartl HM; Mettenleiter TC; Groschup MH; Hoenen T; Diederich S
    J Infect Dis; 2018 Nov; 218(suppl_5):S305-S311. PubMed ID: 29982580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.
    Bornholdt ZA; Turner HL; Murin CD; Li W; Sok D; Souders CA; Piper AE; Goff A; Shamblin JD; Wollen SE; Sprague TR; Fusco ML; Pommert KB; Cavacini LA; Smith HL; Klempner M; Reimann KA; Krauland E; Gerngross TU; Wittrup KD; Saphire EO; Burton DR; Glass PJ; Ward AB; Walker LM
    Science; 2016 Mar; 351(6277):1078-83. PubMed ID: 26912366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An assessment of Ebola-related stigma and its association with informal healthcare utilisation among Ebola survivors in Sierra Leone: a cross-sectional study.
    James PB; Wardle J; Steel A; Adams J
    BMC Public Health; 2020 Feb; 20(1):182. PubMed ID: 32020858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A practical community-based response strategy to interrupt Ebola transmission in sierra Leone, 2014-2015.
    Li ZJ; Tu WX; Wang XC; Shi GQ; Yin ZD; Su HJ; Shen T; Zhang DP; Li JD; Lv S; Cao CL; Xie RQ; Lu HZ; Jiang RM; Cao Z; An ZJ; Li LL; Xu J; Xiong YW; Zang W; Zhang W; Zhang HW; Chen WS; Ling H; Xu W; Cai J; Luo HJ; Xing XS; Zheng CJ; Wei Q; Li XX; Li M; Jiang H; Deng LQ; Chen MQ; Huo X; Xu F; Lai XH; Bai XC; Ye LJ; Yao JY; Yin WW; Sun JJ; Xiao L; Liu FQ; Liu XQ; Fan HW; Kou ZQ; Zhou JK; Zhang H; Ni DX; Samba TT; Li Q; Yu HJ; Wang Y; Liang XF
    Infect Dis Poverty; 2016 Aug; 5(1):74. PubMed ID: 27491387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.
    van Griensven J; Edwards T; de Lamballerie X; Semple MG; Gallian P; Baize S; Horby PW; Raoul H; Magassouba N; Antierens A; Lomas C; Faye O; Sall AA; Fransen K; Buyze J; Ravinetto R; Tiberghien P; Claeys Y; De Crop M; Lynen L; Bah EI; Smith PG; Delamou A; De Weggheleire A; Haba N;
    N Engl J Med; 2016 Jan; 374(1):33-42. PubMed ID: 26735992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving Longitudinal Retinal Observations in a Cohort of Survivors of Ebola Virus Disease.
    Steptoe PJ; Momorie F; Fornah AD; Komba P; Emsley E; Scott JT; Williams SJ; Harding SP; Vandy MJ; Sahr F; Beare NAV; Semple MG
    JAMA Ophthalmol; 2020 Apr; 138(4):395-403. PubMed ID: 32134433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16.
    Kelly JD; Barrie MB; Mesman AW; Karku S; Quiwa K; Drasher M; Schlough GW; Dierberg K; Koedoyoma S; Lindan CP; Jones JH; Chamie G; Worden L; Greenhouse B; Weiser SD; Porco TC; Rutherford GW; Richardson ET
    J Infect Dis; 2018 Mar; 217(8):1214-1221. PubMed ID: 29325149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Airport Entry and Exit Screening during the Ebola Virus Disease Outbreak in Sierra Leone, 2014 to 2016.
    Wickramage K
    Biomed Res Int; 2019; 2019():3832790. PubMed ID: 31915689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015.
    Walker NF; Brown CS; Youkee D; Baker P; Williams N; Kalawa A; Russell K; Samba AF; Bentley N; Koroma F; King MB; Parker BE; Thompson M; Boyles T; Healey B; Kargbo B; Bash-Taqi D; Simpson AJ; Kamara A; Kamara TB; Lado M; Johnson O; Brooks T
    Euro Surveill; 2015 Mar; 20(12):. PubMed ID: 25846490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of CD8
    Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the impact of Ebola control measures in Sierra Leone.
    Kucharski AJ; Camacho A; Flasche S; Glover RE; Edmunds WJ; Funk S
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14366-71. PubMed ID: 26460023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins.
    Koch T; Rottstegge M; Ruibal P; Gomez-Medina S; Nelson EV; Escudero-Pérez B; Pillny M; Ly ML; Koundouno FR; Bore JA; Magassouba N; Dahlke C; Günther S; Carroll MW; Addo MM; Muñoz-Fontela C
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32825479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.